LAKSHMIKANTHA KUMBLA: Open Payments
NPI 1265452098 · GREENVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 34 payments from 6 companies in 2025. Trend: 2023 $501 · 2024 $926 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $247 |
| Otsuka America Pharmaceutical, Inc. | 4 | $177 |
| E.R. Squibb & Sons, L.L.C. | 9 | $164 |
| Alkermes, Inc. | 9 | $143 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
Products named: INGREZZA, COBENFY, ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, FANAPT, ABILIFY MAINTENA.
Industry payments across AL — which companies pay providers there.
